Needham & Company downgraded Cardiovascular Systems (NASDAQ: CSII) from Buy to Underperform, saying positive revenue growth may be a year ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Downgrades

Leerink Partners Cut Price Target on Cardiovascular Systems (CSII) Following Disappointing 2Q and 3Q Guidance January 22, 2016 9:22 AM Cardiovascular Systems (CSII) Tops Q2 EPS by 3c, Offers Q3 GuidanceJanuary 21, 2016 4:15 PM Cardiovascular Systems Reports Fiscal 2016 Second-Quarter Financial ResultsJanuary 21, 2016 4:05 PM